Terms: = Leukemia AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF
1277 results:
1. Supportive care measures for bispecific T-cell engager therapies in haematological malignancies.
Chen LY; Kothari J
Curr Opin Support Palliat Care; 2024 Jun; 18(2):92-99. PubMed ID: 38652455
[TBL] [Abstract] [Full Text] [Related]
2. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
[TBL] [Abstract] [Full Text] [Related]
3. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.
Coyle V; Forde C; Adams R; Agus A; Barnes R; Chau I; Clarke M; Doran A; Grayson M; McAuley D; McDowell C; Phair G; Plummer R; Storey D; Thomas A; Wilson R; McMullan R
Health Technol Assess; 2024 Mar; 28(14):1-101. PubMed ID: 38512064
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
Iat A; Loschi M; Benachour S; Calleja A; Chiche E; Sudaka I; Aquaronne D; Ferrero C; Fenwarth L; Marceau A; Fournier E; Dadone-Montaudie B; Cluzeau T
Cancer Med; 2024 Mar; 13(6):e7103. PubMed ID: 38506267
[TBL] [Abstract] [Full Text] [Related]
5. Novel Therapeutic Targets in Acute Myeloid leukemia (AML).
Wysota M; Konopleva M; Mitchell S
Curr Oncol Rep; 2024 Apr; 26(4):409-420. PubMed ID: 38502417
[TBL] [Abstract] [Full Text] [Related]
6. Integrating serum pharmacochemistry and network pharmacology to explore the molecular mechanisms of Acanthopanax senticosus (Rupr. & Maxim.) Harms on attenuating doxorubicin-induced myocardial injury.
Zhang X; Zhang Q; Yu M; Zhang Y; He T; Qiu Z; Qiu Y; Wang W
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117349. PubMed ID: 38380572
[TBL] [Abstract] [Full Text] [Related]
7. BCR/ABL-Positive Chronic Myeloid leukemia in Children: Current Treatment Approach.
Menger JM; Sathianathen RS; Sakamoto KM; Hijiya N
Curr Oncol Rep; 2024 Mar; 26(3):250-257. PubMed ID: 38340217
[TBL] [Abstract] [Full Text] [Related]
8. Frontline Therapy of CLL-Changing Treatment Paradigms.
Coombs CC
Curr Hematol Malig Rep; 2024 Apr; 19(2):65-74. PubMed ID: 38337108
[TBL] [Abstract] [Full Text] [Related]
9. [Risks of radiodiagnostic examinations in children].
Bernier MO; Hubert DLP; Michel C
Rev Prat; 2024 Jan; 74(1):69-73. PubMed ID: 38329259
[TBL] [Abstract] [Full Text] [Related]
10. Research on different compound combinations of Realgar-Indigo naturalis formula to reverse acute promyelocytic leukemia arsenic resistance by regulating autophagy through mTOR pathway.
Li R; Xue C; Pan Y; Li G; Huang Z; Xu J; Zhang J; Chen X; Hou L
J Ethnopharmacol; 2024 May; 326():117778. PubMed ID: 38310990
[TBL] [Abstract] [Full Text] [Related]
11. The Eleutherococcus senticosus fruits' intractum affects changes in the transepithelial electric potential in the distal section of the rabbit's large intestine and inhibits hyaluronidase.
Graczyk F; Gębalski J; Piskorska E; Małkowska M; Słomka A; Gawenda-Kempczyńska D; Kondrzycka-Dąda A; Olszewska-Słonina D; Styczyński J; Taglialatela-Scafati O; Verpoorte R; Załuski D
J Ethnopharmacol; 2024 May; 325():117847. PubMed ID: 38307357
[TBL] [Abstract] [Full Text] [Related]
12. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway.
Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
[TBL] [Abstract] [Full Text] [Related]
13. How Do We Manage Chronic Lymphocytic leukemia in India.
Karunakaran P; Jain N; Lad DP
Curr Hematol Malig Rep; 2024 Apr; 19(2):56-64. PubMed ID: 38300458
[TBL] [Abstract] [Full Text] [Related]
14. Evaluating testicular tissue for future autotransplantation: focus on cancer cell contamination and presence of spermatogonia in tissue cryobanked for boys diagnosed with a hematological malignancy.
Kourta D; Camboni A; Saussoy P; Kanbar M; Poels J; Wyns C
Hum Reprod; 2024 Mar; 39(3):486-495. PubMed ID: 38227814
[TBL] [Abstract] [Full Text] [Related]
15. Prolymphocytic Leukaemia: an Update on Biology and Treatment.
El-Sharkawi D; Dearden C
Curr Oncol Rep; 2024 Feb; 26(2):129-135. PubMed ID: 38214879
[TBL] [Abstract] [Full Text] [Related]
16. Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems.
Sims NA; Lévesque JP
Curr Osteoporos Rep; 2024 Feb; 22(1):80-95. PubMed ID: 38198032
[TBL] [Abstract] [Full Text] [Related]
17. Treatment of Richter's Transformation with Novel Therapies.
Bajwa A; Habib A; Kittai AS
Curr Hematol Malig Rep; 2024 Apr; 19(2):45-55. PubMed ID: 38194201
[TBL] [Abstract] [Full Text] [Related]
18. Chronic Lymphocytic leukemia: Time-Limited Therapy in the First-Line Setting and Role of Minimal Residual Disease.
Stumpf J; Al-Sawaf O
Curr Oncol Rep; 2024 Feb; 26(2):136-146. PubMed ID: 38175465
[TBL] [Abstract] [Full Text] [Related]
19. Obesity and leukemia: Biological Mechanisms, Perspectives, and Challenges.
Tsilingiris D; Vallianou NG; Spyrou N; Kounatidis D; Christodoulatos GS; Karampela I; Dalamaga M
Curr Obes Rep; 2024 Mar; 13(1):1-34. PubMed ID: 38159164
[TBL] [Abstract] [Full Text] [Related]
20. Modified Danzhi Xiaoyao Powder (MDXP) improves the corneal damage in dry eye disease (DED) mice through phagocytosis.
Liu P; Jiang P; Yu Y; Tan K; Qin GY; Liu T; Tian S; Peng J; Peng Q
J Ethnopharmacol; 2024 Mar; 321():117544. PubMed ID: 38070838
[TBL] [Abstract] [Full Text] [Related]
[Next]
